Cancer Targeted Technology

Cancer Targeted Technology is designing and patenting small molecular weight enzyme inhibitors with unique and exceptional imaging and drug delivery properties. Cancer Targeted Technology (CTT) develops innovative targeted agents for cancer that accurately detect, stratify and treat early and advanced disease, and monitor treatment efficacy to improve patient survival and quality of life. CTT is a biotechnology company commercializing innovative small molecules that bind pivotal enzyme targets in cancer.